Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

NCT00734045 is registered in ClinicalTrials.gov with Nanogen, Inc. as lead sponsor.

NCT NCT00734045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00734045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples
Lead sponsor
Nanogen, Inc.
Phase
Observational
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2008
Enrollment
450 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure (chf)